There is extensive evidence that SIRT1 reduction is involved in AD tau pathology, and tau acetylation of lysine 28 inhibits tau function via impaired tau-microtubule interactions, promoting tau aggregation (Cohen et al., 2011). This evidence concerns the gene SIRT1 and Alzheimer disease.